Enhanced prostaglandin F 2α formation in human pregnancy and the effect of increased oily fish intake: Results from the Salmon in Pregnancy Study

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 86, Issue 1-2, 2012, Pages 35-38

  Helmersson Karlqvist, Johanna ^a,b   Miles, Elizabeth A ^c   Vlachava, Maria ^c   Kremmyda, Lefkothea Stella ^c   Noakes, Paul S ^c   Diaper, Norma D ^c   Godfrey, Keith M ^c,d,e   Calder, Philip C ^c,d   Basu, Samar ^a,b,f  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Allergy; COX; N 3 long chain polyunsaturated fatty acids; Pregnancy; Prostaglandin F 2 ; Salmon

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN F2 ALPHA; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PHOSPHATIDYLCHOLINE; PROSTAGLANDIN F2 ALPHA; 15 KETO 13,14 DIHYDROPROSTAGLANDIN F2ALPHA; 15-KETO-13,14-DIHYDROPROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE;

ADULT; ARTICLE; BIRTH; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; PREGNANCY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SALMON; UNITED KINGDOM; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET; GESTATIONAL AGE; SEA FOOD; TIME; URINE;

ADULT; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACID; DIET; DINOPROST; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GESTATIONAL AGE; HUMANS; PHOSPHATIDYLCHOLINES; PREGNANCY; SALMON; SEAFOOD; TIME FACTORS;

EID: 84155172154     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.10.008     Document Type: Article

References (32)

1. Calder P.C., Kremmyda L.S., Vlachava M., Noakes P.S., Miles E.A. Is there a role for fatty acids in early life programming of the immune system?. Proc. Nutr. Soc. 2010, 69:373-380.
2. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001, 36:1007-1024.
3. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 2009, 91:791-795.
4. Moore M.L., Peebles R.S. Update on the role of prostaglandins in allergic lung inflammation: separating friends from foes, harder than you might think. J. Allergy Clin. Immunol. 2006, 117:1036-1039.
5. Park G.Y., Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290:L797-805.
6. Kremmyda L.S., Vlachava M., Noakes P.S., Diaper N.D., Miles E.A., Calder P.C. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin. Rev. Allergy Immunol. 2011, 41:36-66.
7. Calder P.C. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77:327-335.
8. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83:1505S-1519S.
9. Basu S. Radioimmunoassay of 15-keto-13.14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot. Essent. Fatty Acids 1998, 58:347-352.
10. Basu S. Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation. Med. Res. Rev. 2007, 27:435-468.
11. Samuelsson B. Quantitative aspects on prostaglandin synthesis in man. Adv. Biosci. 1973, 7-14.
12. Basu S., Kindahl H., Harvey D., Betteridge K.J. Metabolites of PGF2 alpha in blood plasma and urine as parameters of PGF2 alpha release in cattle. Acta Vet. Scand. 1987, 28:409-420.
13. Basu S. Maternal recognition of pregnancy-a review of the literature. Nord. Vet. Med. 1985, 57-79.
14. Miles E.A., Noakes P.S., Kremmyda L.-S., et al. The salmon in pregnancy study- study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. Am. J. Clin. Nutr. 2011, 10.3945/ajcn.110.001636.
15. L. Scientific Advisory Committee on Nutrition (SACN)/Committee on Toxicity (COT). Advice on Fish Consumption: Benefits and Risks. The Stationery Office, 2004. Available at: http://www.food.gov.uk.
16. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., Calder P.C. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur. J. Clin. Invest. 2000, 30:260-274.
17. Rees D., Miles E.A., Banerjee T., et al. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am. J. Clin. Nutr. 2006, 83:331-342.
18. Fischer S., von Schacky C., Schweer H. Prostaglandins E3 and F3 alpha are excreted in human urine after ingestion of n-3 polyunsaturated fatty acids. Biochim. Biophys. Acta 1988, 963:501-508.
19. Peterson L.D., Jeffery N.M., Thies F., Sanderson P., Newsholme E.A., Calder P.C. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 1998, 33:171-180.
20. Lee T.H., Hoover R.L., Williams J.D., et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 1985, 312:1217-1224.
21. Nälsen C., Vessby B., Berglund L., et al. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J. Nutr. 2006, 136:1222-1228.
22. Kindahl H., Basu S., Fredriksson G., Goff A., Kunavongkrit A., Edqvist L.-E. Levels of prostaglandin F2alpha metabolites in blood and urine during early pregnancy. Anim. Reprod. Sci. 1984, 133-148.
23. Pakrasi P.L., Dey S.K. Blastocyst is the source of prostaglandins in the implantation site in the rabbit. Prostaglandins 1982, 24:73-77.
24. Parr M.B., Parr E.L., Munaretto K., Clark M.R., Dey S.K. Immunohistochemical localization of prostaglandin synthase in the rat uterus and embryo during the peri-implantation period. Biol. Reprod. 1988, 38:333-343.
25. McCracken J.A., Custer E.E., Lamsa J.C. Luteolysis: a neuroendocrine-mediated event. Physiol. Rev. 1999, 79:263-323.
26. Green K., Bygdeman M., Toppozada M., Wiqvist N. The role of prostaglandin F2alpha in human parturition. Endogenous plasma levels of 15-keto-13.14-dihydro-prostaglandin F2alpha during labor. Am. J. Obstet. Gynecol. 1974, 120:25-31.
27. Gibb W. The role of prostaglandins in human parturition. Ann. Med. 1998, 30:235-241.
28. Olson D.M. The role of prostaglandins in the initiation of parturition. Best Pract. Res. Clin. Obstet. Gynaecol. 2003, 17:717-730.
29. Makino S., Zaragoza D.B., Mitchell B.F., Robertson S., Olson D.M. Prostaglandin F2alpha and its receptor as activators of human decidua. Semin. Reprod. Med. 2007, 25:60-68.
30. Nakayama K., Haruna M., Matsuzaki M., Sekine K., Murashima S. Changes in 13, 14-dihydro-15-keto-prostaglandin F2alpha levels in saliva during pregnancy, labor and the postpartum period. J. Obstet. Gynaecol. Res. 2010, 36:27-33.
31. Hamberg M. Quantitative studies on prostaglandin synthesis in man. 3. Excretion of the major urinary metabolite of prostaglandins F1 alpha and F2 alpha during pregnancy. Life Sci. 1974, 14:247-252.
32. Lee S.E., Romero R., Park I.S., Seong H.S., Park C.W., Yoon B.H. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J. Matern. Fetal Neonat. Med. 2008, 21:89-94.